The high-profile stockpicker is the eye disorder treatment hopeful’s biggest shareholder. Ahead of the results of a crucial ...

(Reuters) -Drugmaker AstraZeneca said on Monday it will buy biotechnology firm EsoBiotec for up to $1 billion. EsoBiotec's ...

This oversubscribed Series A funding round was led by General Catalyst with additional investment from new investors, British ...

Arizona State Retirement System lessened its stake in Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) by 6.3% in the 4th ...

Acquisition includes EsoBiotec’s world-leading in vivo delivery platform with potential to transform cell therapyMONT-SAINT-GUIBERT, Belgium, March 17, 2025 (GLOBE NEWSWIRE) -- EsoBiotec SA, a ...

In November 2024, Zealand Pharma presented detailed results from the Phase 1b 16-week multiple ascending dose (MAD) trial at ...

Seres Therapeutics (NASDAQ:MCRB – Free Report) had its price objective trimmed by The Goldman Sachs Group from $1.00 to $0.75 in a report released on Friday,Benzinga reports. The brokerage currently ...

Colossal Biosciences, a Dallas-based biotechnology and genetic engineering startup valued at $10 billion, has raised $435 ...

INOVIQ (ASX: IIQ) has appointed Dr Emma Ball as Chief Commercial Officer (CCO), effective 22 April 2025. Dr Ball will oversee ...

How does your work relate to Nigeria’s quest for economic renewal? My work is inspired by the need to contribute to the ...

All these factors are forcing the healthcare delivery ecosystem to undergo a transformation that will be relevant for the ...

A biotechnology company whose goal is to bring back the wooly mammoth says its recent small step is big news. Colossal ...